Search

everythinglearnresearchcommunity

for

Search:↓

Personalized treatment considering atopic status and cytokine profiles may help in managing pediatric alopecia areata.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

4-(Ethoxycarbophenyl) retinamide is much less toxic than other retinoids.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe symptoms and organ damage in mice.

Ixekizumab has known and some unexpected side effects.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Corticosteroid therapy reduces specific immune cells and promotes hair growth in alopecia areata patients.

Type 2 immunity helps control mite growth in hair follicles, preventing damage.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Reflectance confocal microscopy is useful for diagnosing and monitoring skin diseases, but it has limitations and requires expertise for correct use.

The ID2 gene can help distinguish between sensitizers and irritants in skin cells.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

EGF receptor is crucial for skin health and its inhibitors can cause skin rashes.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

Alopecia areata patients have higher IFN-γ and low vitamin D3 levels.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Some patients on immune therapy for melanoma may develop scarring hair loss, but cancer treatment remains effective.

CD27 and IL-35 can help diagnose alopecia areata linked to bacterial infections.

Tridax procumbens plant parts boost immune response in mice.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.